Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) has provided an update.
EZZ Life Science Holdings Limited has strengthened its board by appointing Christine Chen as Executive Director and Janice Hsu as Non-Executive Director, effective immediately. Chen, a long-standing executive with the company and a qualified accounting and tax professional, formalises her pivotal role in finance, compliance and governance, providing continuity and technical depth at the executive level. Hsu brings experience in administration, stakeholder engagement and community services, adding a people-focused and governance-oriented perspective that is expected to support board oversight as EZZ scales its operations and executes its growth strategy.
The most recent analyst rating on (AU:EZZ) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is an Australian-listed company in the life sciences sector, focused on developing and marketing health and wellness products. The company is pursuing a growth strategy that emphasises strong governance, compliance, and operational scalability as it expands its operations and organisational structure.
Average Trading Volume: 72,169
Technical Sentiment Signal: Sell
Current Market Cap: A$85.15M
For a thorough assessment of EZZ stock, go to TipRanks’ Stock Analysis page.